← All stories
Markets
What Does Jazz Pharmaceuticals (NASDAQ:JAZZ) Tell Us About Cannabidiol As Licensed Medicine?
Highlights The group's cannabidiol oral solution holds marketing authorisation for specific treatment-resistant epilepsy conditions. New clinical and real-world evidence has been presented at major neurology and epilepsy meetings. The medic…
Covered by 1 outlet
All coverage · 1 article